[Arbidole--a new drug for prevention of influenza and acute viral respiratory infections in children].
The antiviral drug arbidole reduces influenza and acute respiratory diseases (ARD) in children by 1.5-2 times when given in a dose of 0.1-0.2 g 2-3 or 5 times a week, by making influenza and ARD milder and decreasing their duration by 1.4-2.8 days. Unified regimens for prophylactic use of arbidole in influenza and ARD in children and adults are proposed.
Beliaev
A L
AL
Burtseva
E I
EI
Slepushkin
A N
AN
Beliaeva
N A
NA
Nosik
N N
NN
Lavrukhina
L A
LA
Maksimova
L N
LN
Feklisova
L V
LV
Shibekova
V M
VM
Danina
N F
NF
Tselipanova
E E
EE
Bylinkina
S A
SA
Voĭtsekhovskaia
E M
EM
Sominina
A A
AA
D000293:Adolescent; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male; D012141:Respiratory Tract Infections / Q000517:prevention & control* / Q000821:virology*; D016896:Treatment Outcome; D014777:Virus Diseases / Q000517:prevention & control*; D013440:Sulfides
D000998:Antiviral Agents; D007211:Indoles; C086979:umifenovir; D013440:Sulfides
Arbidol--novoe sredstvo dlia profilaktiki grippa i ostrykh respiratornykh virusnykh infektsiĭ u deteĭ.